ENT device cassification
This article was originally published in The Gray Sheet
Executive Summary
FDA proposes to classify nasal dilators, intranasal splints and bone particle collectors into Class I and to exempt the devices from 510(k) requirements in a May 11 Federal Register notice. FDA's Ear, Nose, and Throat Devices Advisory Panel recommended placing the devices into Class I during a 1990 panel meeting ("The Gray Sheet" Oct. 29, 1990, p. 8). FDA says it had "inadvertently omitted classifying" these types of devices in 1986 when the agency published a final rule classifying ear, nose, and throat devices. Comments are due by Aug. 10...
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.